Your search for medicaid returned 390 results

By adopting a comprehensive strategy that balances clinical insights, lifestyle interventions and economic considerations, staff members can unlock the potential for improved outcomes and elevate the facility’s...

Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.

Family caregivers face many challenges in helping their loved ones who are living with dementia, not the least of which is navigating the insurance landscape for long-term care. That’s according to the...

“Congress should consider the steps it can take at the federal level, including expanding the necessary workforce and improving dementia training standards and access,” as part of efforts to “help...

Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.

CMS: Expect final nursing home staffing rule this year … Johns Hopkins identifies opportunities for strengthening direct care workforce … University of Buffalo to invest $4M in aging research as...

The findings were seen in older hospitalized patients with advanced chronic obstructive pulmonary disease, dementia or kidney failure.

The population-attributable fraction for nongenetic risk factors combined is similar for men and women, but it varies across racial and ethnic groups.

A high false-positive rate was seen when used in primary care with a diverse patient population.

Researchers have found a way to deliver Alzheimer’s drugs faster via focused ultrasound technology, a new study shows.